Abstract:Rhenium(I) organometallic compounds (C 1 -C 6 ) with substituted quinoxaline Schiff base-based ligands (L 1 -L 6 ) were synthesized and characterized using spectroscopic techniques such as 1 HNMR , LC-MS, FT-IR spectroscopy, conductivity measurement, and elemental analysis. CT-DNA was tested under the impact of complexes using absorbance titration and viscosity measuring techniques to evaluate the binding capacities and manner. The compounds bind to the DNA by partial intercalation. The K b values for all synthesized compounds are in the range of 0.44 to 1.72×10 5 M −1 in the absorption titration experiment. The evaluation of compounds binding to BSA was carried out using a fluorescence quenching study and the K sv values were observed in the range of 0.93 to 1.67×10 4 M −1 . The K sv values for the fluorescence quenching-based DNA binding investigation were observed in the range of 0.75 to 1.87×10 4 M −1 . The findings of the molecular docking investigations support the previously described point to an intercalation type of binding. The protein binding studies of all the synthesized compounds were examined using an absorption titration experiment, and the K b values for all of the compounds range from 0.64 to 1.35×10 4 M −1 . The structures of Re (I) complexes were optimized using DFT investigations. The antibacterial activity of organometallic compounds was tested against two Gram-positive and three Gram-negative pathogens, and the results showed that organometallic compounds outperform all ligands in this regard. The pharmacokinetic profile of each synthesized molecule was assessed as part of the ADME investigation using the online tools SwissADME and admetSAR. The MCF-7 cancer cell line was used to examine the anticancer effects of the compounds.

The Synthesis and Biological Evaluation of Some C-9 and C-10 Substituted Derivatives of the RNA Polymerase I Transcription Inhibitor CX-5461

Synthesis and Preliminary Studies of Biological Activity

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles

Synthesis of Novel Ral Inhibitors: an in Vitro and in Vivo Study

Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.

Design, one-pot novel synthesis of substituted acridine derivatives: DFT, structural characterisation, ADME and anticancer DNA polymerase epsilon molecular docking studies

Synthesis, Molecular Modeling and Biological Evaluation of 2-Aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3h)-thione Quinolone Derivatives As Novel Anticancer Agent

Synthesis and Potent Antileukemic Activities of 10-Benzyl-9(10h)-acridinones

Novel Synthetic 2-Amino-10-(3,5-dimethoxy)benzyl-9(10h)-acridinone Derivatives As Potent DNA-binding Antiproliferative Agents.

Synthesis and Biological Evaluation of Novel C6-cyclo Secondary Amine Substituted Purine Steroid-Nucleosides Analogues.

Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities

Synthesis, Molecular Modeling and Biological Evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide Derivatives As Potential Anticancer Agents

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and Biological Evaluation of Novel 2,4,5-Substituted Pyrimidine Derivatives for Anticancer Activity

Synthesis of new polyoxin derivatives and their activity against chitin synthase from Candida albicans.

Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction

Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or Α-Cyanoarylmethyl)-3,4-dihydropyrimidin-4(3h)-ones As Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Synthesis and characterization of quinoxaline-based rhenium(I) organometallic compounds: Biological and computational applications